Implantica AG (FRA:8IM1)

Market Cap	1.33B
Revenue (ttm)	1.99M
Net Income (ttm)	-19.74M
Shares Out	n/a
EPS (ttm)	-0.07
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	7,265
Average Volume	n/a
Open	4.845
Previous Close	4.770
Day's Range	4.845 - 4.845
52-Week Range	2.250 - 7.540
Beta	n/a
RSI	46.61
Earnings Date	Feb 13, 2026

About Implantica AG

Implantica AG engages in the research and distribution of medical implants in Switzerland. The company’s lead product candidate is RefluxStop, a passive CE-marked implant for prevention of gastroesophageal reflux disease. It focuses on two treatment areas, Gastrointestinal surgery and Urology. It is also involved in the development of eHealth platform, a digital health system to support its pipeline of smart medical implants designed for a safe and secure control and monitoring over the internet; e-InVivo, a sensor implants to monitor a multitu...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 2015
• Employees: 50
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 8IM1

Financial Performance

In 2024, Implantica AG's revenue was 1.94 million, an increase of 37.50% compared to the previous year's 1.41 million. Losses were -23.33 million, -1.73% less than in 2023.